It is shown from the kinetics of inhibition of cholinesterase by N-methylcarbamates and organophosphates that the LD50 dose is likely to be a much greater multiple of the dose causing signs of poisoning in 50%-of the animals (the ED50) for the carbamates than for the organophosphates. The expected difference was demonstrated by a comparison of the LD50s and ED50s, intravenous and intramuscular, of five carbamates (2-isopropoxyphenyl N-methylcarbamate, 3-isopropylphenyl N-methylcarbamate, 6-chloro-3,4-xylyl N-methylcarbamate, 3,4,5-trimethylphenyl N-methyl-carbamate, and 3-methyl-5-isopropylphenyl N-methylcarbamate) and two organophosphorus compounds (diethyl 4-nitrophenyl phosphate and dimethyl 4-nitrophenyl phosphate). The slightest evoked tremor was chosen as the most reliable sign of poisoning from which to estimate the ED50 values. Carbamates gave much greater LD50/ED50 ratios than organophosphorus compounds. It is likely that occupational exposure to carbamates will produce incapacitating symptoms at doses well below lethal levels.
Two groups of insecticides with anticholinesterase action are in widespread use-organophosphorus compounds and N-methylcarbamate esters. There are good theoretical reasons for expecting that the carbamates will produce the first distinct signs of poisoning at very much smaller fractions of their LD50 values than will the organophosphorus compounds.
Thus organophosphorus compounds can be regarded as irreversible inhibitors, so that inhibition of cholinesterase is progressive, as described by Aldridge and Davison (1952) . For such inhibitors the activities of the uninhibited and partially inhibited enzymes are related by the equation:
inee volvi = kicit (1) where vo and vi are the activities before and after inhibition, ci is the concentration of inhibitor acting for time t, and ki is the rate constant for the reaction between inhibitor and enzyme.
In the case of carbamates, interaction with the enzyme involves both inhibition and re-activation (Wilson, Hatch, and Ginsburg, 1960) , so that after a certain time an equilibrium is reached, i.e., the rates of inhibition and re-activation are equal. The equilibrium is described by the equation (Reiner, unpublished) : (2) where K stands for the equilibrium constant. This equation is equally applicable whether equilibrium is reached through carbamylation of the enzyme or by the formation of a reversible complex between enzyme and inhibitor.
In the Figure the inhibition of cholinesterase by carbamates and organophosphorus compounds is presented at various concentrations of inhibitor. The degree of inhibition was calculated from equation 1 for organophosphorus compounds and from equation 2 for carbamates.
In Figure a concentration, whereas for a two-to three-fold increase of the inhibitor concentration the difference in the degree of inhibition is much smaller. To produce, for instance, 87-5% inhibition, the concentration of the organophosphorus compound has to be increased 15-6 times and that of the carbamate as much as 49 times. For a 99 % inhibition, the ratio of the multiples amounts to 345 :636. On the other hand, 50% inhibition is produced by similar increases in organophosphate and carbamate concentrations, the multiples being 5 and 7 5 respectively.
In Figure b the concentration producing 87-5% inhibition was set as 1. In this case at any concentration of inhibitor below 1 the cholinesterase activity is lower in carbamate inhibition. For instance, onetenth of the concentration of the organophosphorus compound produces 21 % inhibition, whereas in the carbamate the same fraction produces 43 % inhibition.
The above discussion applies strictly only in vitro. In vivo the inhibitors are likely to be metabolized, and inhibition is a complex function of dose, metabolism, and distribution. Presumably, however, the degree of inhibition required to produce signs of poisoning is the same whatever the inhibitor, and likewise the degree of inhibition to cause death. Therefore, unless metabolism and distribution vary greatly with the dose, the main conclusion should still be correct. A very much higher multiple of the dose that causes signs of poisoning should be required to produce the additional inhibition needed to cause death from carbamates than from organophosphates. This is shown to be true from a study of the effects of five carbamates and two organophosphates in rats. The doses causing the first signs of poisoning in 50 % of the rats are referred to as ED50 (effective dose) values.
Materials and Methods
Five carbamatest (2-isopropoxyphenyl N-methylcarbamate (OMS-33), 3-isopropylphenyl N-methylcarbamate (OMS-162), 6-chloro-3,4-xylyl N-methylcarbamate (OMS-174), 3,4,5-trimethylphenyl Nmethylcarbamate (OMS-597), and 3-methyl-5-isopropylphenyl N-methylcarbamate (OMS-716)) and two organophosphates4 (diethyl 4-nitrophenyl phosphate, paraoxon, and dimethyl 4-nitrophenyl phosphate, paraoxon-methyl) were used, and their ED50
and LD50 values were determined after a single intravenous or intramuscular injection into male albino rats (200-300 g.). For Weil (1952) .
A few preliminary experiments were carried out on dogs in which we took no measures to evoke tremors.
Results
Intravenous LD50 and ED50 values for five carbamates and two organophosphorus compounds are given in Table 1 ; in the last column (A/B) the ratio between the two values is shown. In Table 2 LD50 and ED50 values obtained after intramuscular injection of the same compounds are presented; the 
